*By Samantha Errico*
Your days to travel in 2018 may be numbered, but 2019 beckons. So what's ahead for the travel industry next year? Lola.com CEO Mike Volpe joined Cheddar to present his predictions for travel in 2019.
**Day-Rate Hotels**
"In this world where everyone wants to be faster and more agile, your needs around business are changing," Volpe told Cheddar Friday. Hotels are incorporating flexible check-in times for travelers who take red eyes, and offering hourly rates for visitors who are only in town for the day. Hotels are adapting to the pace of the modern travel and the growing demand of customers.
**Out with Corporate Travel, in with Consumer Travel**
The business travel industry is expected to hit $1.6 trillion by 2020, and more companies are trying to exploit the market. Companies are meeting the growing demands of the market by "taking the consumer speed and agility from the consumer travel world into the corporate travel world," Volpe said. Travel companies are racing to find the easiest booking system possible, Volpe said. "The average corporate travel system takes a person about an hour to book their flight and hotel for an upcoming trip," he added.
Seth Schachner, Managing Director at Strat Americas, on Hollywood's latest blockbusters utilizing content creation. Plus, the future of YouTube and TikTok.
Ashley Gold, Axios' Tech/Policy reporter, discusses what the future of Google and search engines will look like after the tech giant faces an antitrust trial.
A labor rights group has alleged that Starbucks sourced coffee from a major Brazilian cooperative whose member farms were cited for keeping workers in slave-like conditions.
X, the social media platform owned by Trump adviser Elon Musk, is challenging the constitutionality of a Minnesota ban on using deepfakes to influence elections and harm candidates.
Seth Goldstein, Equity Strategist at Morningstar, breaks down Tesla's earnings report, talks Musk's future with the company and how stocks have responded.
Senior Health Correspondent for TIME, Alice Park, gives us a deeper look into how Eli Lilly's new pill orforglipron may change the healthcare industry.
